Comprehensive analysis to identify the RP11–478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC), accounting for 70–80% of all renal cell carcinomas, is a common malignancy. Survival rates decrease significantly in patients with advanced and metastatic ccRCC. Furthermore, ccRCC is less responsive to radiation and chemotherapy than other cancers. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Kai, Song, Guoda, Chen, Bingliang, Gao, Xintao, Liu, Chaofan, Miao, Jianping, Ruan, Yajun, Luan, Yang, Chen, Xin, Liu, Jihong, Li, Qinyu, Liu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445397/
https://www.ncbi.nlm.nih.gov/pubmed/36054996
http://dx.doi.org/10.1016/j.tranon.2022.101525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445397/
https://www.ncbi.nlm.nih.gov/pubmed/36054996
http://dx.doi.org/10.1016/j.tranon.2022.101525

Ejemplares similares